Albendazole

Welcome to Dwaey, specifically on Albendazole page.
This medicine contains important and useful components, as it consists of
Albendazole is available in the market in concentration.

Generic Name of Albendazole - Learn More

Albendazole

Albendazole Precaution - What You Need to Know

Albendazole is an anthelmintic drug commonly used to treat various parasitic infections, including those caused by roundworms, tapeworms, and other helminths. While it is generally well tolerated, certain precautions should be considered:
- Pregnancy: Albendazole is classified as a Category C drug during pregnancy, meaning that it may cause fetal harm based on animal studies, but there are no well-controlled studies in humans. It should be used during pregnancy only if the potential benefit outweighs the potential risk. It is especially advised to avoid albendazole during the first trimester unless absolutely necessary.
- Breastfeeding: Albendazole is excreted in breast milk, and its safety during breastfeeding is not well-established. Caution is recommended, and its use in nursing mothers should only be considered if the benefits outweigh the risks to the infant.
- Liver Function: Albendazole is metabolized in the liver, and patients with liver dysfunction should be closely monitored. Liver enzyme levels should be checked before and during therapy, as the drug can cause liver toxicity. Patients with severe liver impairment should generally avoid albendazole unless absolutely necessary.
- Bone Marrow Suppression: Rarely, albendazole can cause bone marrow suppression, including leukopenia, thrombocytopenia, and agranulocytosis. Monitoring blood counts during therapy is recommended, especially in long-term treatments.
- Allergic Reactions: In patients with a history of hypersensitivity to albendazole or other benzimidazole drugs, it should not be used due to the risk of severe allergic reactions.

Monitoring Parameters:
- Liver function (liver enzymes, bilirubin levels) should be regularly monitored during therapy, particularly in patients receiving prolonged treatment or those with pre-existing liver conditions.
- Hematologic monitoring is essential for early detection of bone marrow suppression. Complete blood counts (CBC) should be checked before starting treatment and periodically thereafter.
- Clinical response to the drug should be assessed by monitoring for improvements in the symptoms of the parasitic infection.

Albendazole Indication - Uses and Benefits

Albendazole is primarily indicated for the treatment of parasitic infections caused by a variety of helminths. Common indications include:
- Nematode infections: Such as ascariasis, hookworm infections, and trichuriasis.
- Cestode infections: Including tapeworms like echinococcosis (hydatid disease) and neurocysticercosis, where albendazole is often the drug of choice.
- Giardiasis and Strongyloidiasis: Albendazole is also effective in treating giardiasis, caused by *Giardia lamblia*, and infections caused by *Strongyloides stercoralis*.
- Onchocerciasis: Albendazole can be used in combination with other antiparasitic agents for onchocerciasis (river blindness).

Off-label uses of albendazole may include treatment of various other parasitic infections, particularly those resistant to first-line treatments, or for parasites affecting immunocompromised individuals. However, off-label use should be considered only after consultation with an infectious disease specialist.

Albendazole Contraindications - Important Warnings

Albendazole is contraindicated in the following conditions:
- Hypersensitivity: Patients with known hypersensitivity to albendazole or any of its components should avoid the drug due to the risk of severe allergic reactions.
- Pregnancy: It is contraindicated in pregnant women, particularly during the first trimester, due to the potential teratogenic effects observed in animal studies.
- Severe Liver Impairment: Albendazole is metabolized by the liver, and in patients with severe liver impairment, the drug may accumulate, leading to toxicity. Therefore, its use should be avoided in such patients.
- Bone Marrow Suppression: Patients with pre-existing bone marrow disorders or those who are undergoing long-term therapy may be at increased risk for bone marrow suppression, and albendazole should be avoided in these situations.

Albendazole Side Effects - What to Expect

Albendazole is generally well-tolerated, but side effects can occur, especially with long-term or high-dose therapy. Common and mild side effects include:
- Gastrointestinal Distress: Nausea, vomiting, and abdominal pain are common, particularly during the first few days of treatment.
- Headache: Some patients may experience mild headaches, especially during prolonged treatment courses.
- Dizziness and Fatigue: Dizziness or general tiredness may occur, especially if used in high doses or for prolonged periods.
- Elevated Liver Enzymes: Liver function abnormalities, including elevated liver enzymes (ALT, AST), are common and require regular monitoring.

More serious, though rarer, side effects include:
- Hepatotoxicity: In rare cases, albendazole can cause severe liver damage, including hepatitis and jaundice. Liver enzyme monitoring is essential during treatment, and discontinuation may be required if significant liver dysfunction occurs.
- Bone Marrow Suppression: Prolonged use of albendazole can lead to bone marrow suppression, resulting in conditions such as leukopenia, thrombocytopenia, and agranulocytosis. Blood counts should be monitored regularly.
- Allergic Reactions: Severe allergic reactions, including anaphylaxis, are rare but may occur in sensitive individuals.

To minimize side effects, albendazole should be taken with food to reduce gastrointestinal discomfort, and patients should be closely monitored for liver function and blood cell counts during prolonged therapy.

Albendazole Pregnancy Category ID - Safety Information

3

Albendazole Mode of Action - How It Works

Albendazole is a broad-spectrum anthelmintic that works by inhibiting the polymerization of tubulin in parasitic cells. This disruption in microtubule formation affects the ability of the parasite to take in glucose, which leads to a depletion of the parasite’s energy reserves and eventual death. This mechanism is effective against a wide range of parasitic helminths, including roundworms, tapeworms, and flukes.

Albendazole’s activity is dose-dependent. At lower doses, it inhibits the microtubule formation in intestinal helminths, while at higher doses, it can disrupt the ability of parasites to replicate and invade tissues. Its ability to target both the intestinal and tissue-dwelling parasites makes it an ideal drug for treating systemic parasitic infections such as cysticercosis or hydatid disease. The drug is well-absorbed orally and undergoes extensive first-pass metabolism to its active metabolite, albendazole sulfoxide, which is responsible for its therapeutic effect.

Albendazole Drug Interactions - What to Avoid

Albendazole can interact with several medications, which can either reduce its effectiveness or lead to serious side effects:
- CYP450 Interactions: Albendazole is metabolized by the liver, particularly through the CYP450 system (mainly CYP3A4). Concomitant use with CYP3A4 inhibitors (e.g., ketoconazole, itraconazole) can increase albendazole levels, potentially increasing the risk of hepatotoxicity and other side effects. Conversely, CYP3A4 inducers (e.g., rifampin, carbamazepine) may lower albendazole levels, reducing its efficacy.
- Corticosteroids: When used with corticosteroids, there is an increased risk of adverse effects such as gastrointestinal bleeding or ulceration, especially with long-term use.
- Other Anthelmintics: When albendazole is used in combination with other anthelmintic drugs (e.g., praziquantel), there may be enhanced effects. Caution is needed to avoid potential toxicity.
- Alcohol: There is no direct interaction with alcohol, but the use of alcohol should be avoided to minimize any possible gastrointestinal irritation or hepatic stress when combined with albendazole.

Albendazole Adult Dose - Recommended Dosage

The usual dose of albendazole for adults depends on the type of infection being treated:
- For intestinal nematode infections (e.g., ascariasis, hookworm): 400 mg once daily for 3 days.
- For cysticercosis: 15 mg/kg/day, divided into two doses, for 8-28 days depending on the severity.
- For hydatid disease: 10-15 mg/kg/day, divided into two doses, for 28 days.
Doses may be repeated after a course of therapy or extended if needed for more complicated infections.

Albendazole should be taken with food to enhance absorption and reduce gastrointestinal irritation. Therapy may need to be adjusted based on the clinical response and side effect profile.

Albendazole Child Dose - Dosage for Children

The dosing of albendazole in children varies based on their weight and the type of parasitic infection:
- For intestinal infections, the typical dose is 10 mg/kg once daily for 3 days.
- For hydatid disease or cysticercosis, dosing is based on the child’s weight, generally 15 mg/kg/day, divided into two doses, for up to 28 days.
The use of albendazole in children younger than 2 years is generally not recommended unless advised by a pediatric specialist due to limited safety data.

Close monitoring for side effects such as liver enzyme abnormalities and hematologic changes is crucial during treatment, particularly in young children undergoing prolonged therapy.

Albendazole Renal Dose - Dosage for Kidney Conditions

In patients with renal impairment, albendazole can generally be used without significant dosage adjustments. However, patients with severe renal insufficiency should be monitored closely for potential accumulation of the drug or its metabolites. Although albendazole is primarily metabolized by the liver, renal impairment may affect its clearance, and renal function should be assessed periodically.